Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Biochem Pharmacol. 2016 Dec 8;126:51–68. doi: 10.1016/j.bcp.2016.12.003

Fig. 4.

Fig. 4

Cytotoxic activity of pachycladin A treatment against the non-tumorigenic human mammary epithelial MCF10A cells, compared to DMSO as a vehicle control. Error bars indicate the S.D. of N=3/dose. Doxorubicin was used as a positive control at 10 μM.